Axial Spondyloarthritis (AxSpA): Clinical Trials

16 trials for Axial Spondyloarthritis (AxSpA), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 5 recruiting, 2 not yet recruiting, 1 active not recruiting. 5 Not applicable, 3 Phase 1, 3 Phase 4, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable5Completed 3, Not yet recruiting 1, Recruiting 1
Phase 13Completed 2, Recruiting 1
Phase 43Completed 1, Not yet recruiting 1, Recruiting 1
Phase 21Recruiting 1

Follow Axial Spondyloarthritis (AxSpA): new trials by email Literature Review of Axial Spondyloarthritis (AxSpA) trials Research Report on Axial Spondyloarthritis (AxSpA)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Pragmatic Trial of Interleukin-17 Inhibition Versus Janus Kinase Inhibition After Tumor Necrosis Factor-alpha Inhibitor Failure in Axial Spondyloarthritis
Secukinumab (IL-17i ), Upadacitinib (JAKi) - Axial Spondyloarthritis (AxSpA)
Phase 4Not yet recruitingThe University of Texas Health Science Center, Houston402026-11-012026-10-14
Postural Biofeedback and Exercise in Axial Spondyloarthritis
Standard Exercise Program, Wearable Postural Biofeedback - Axial Spondyloarthritis (AxSpA), Ankylosing Spondylitis (AS)
Not applicableNot yet recruitingIstanbul University - Cerrahpasa382026-10-012026-08-21
The REFLECT Study- Flares in axSpA
Axial Spondyloarthritis (AxSpA), Axial Spondyloarthritis, Non-Radiographic
Active not recruitingRoyal United Hospitals Bath NHS Foundation Trust402026-06-012026-07-07
Multicenter Validation of the 2025 Classification Criteria for Axial Spondyloarthritis
Diagnostic Assessment - Axial Spondyloarthritis (AxSpA), Spondyloarthritis (SpA)
RecruitingChinese PLA General Hospital2472026-04-102026-07-24
REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases
JAKi dose reduction strategy, JAKi disease activity guided continuation of same dose strategy - Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA)
Phase 4RecruitingSint Maartenskliniek2002025-09-152025-09-17
EAST-1 (ERAP-inhibition in Axial Spondyloarthritis Trial - 1)
Part A - Single Ascending Dose (SAD) in Healthy Human Volunteers, Part B - Multiple Ascending Dose (MAD) in participants with axSpA, Part C - Safety expansion cohort in participants with axSpA - Axial Spondyloarthritis (AxSpA)
Phase 1 / Phase 2RecruitingGrey Wolf Therapeutics1402025-07-282026-09-18
Effects of Yoga Therapy in Rehabilitation Compared to Physiotherapy in Moderate Axial Spondyloarthritis (axSPA)
Yogatherapy, Physiotherapy - Axial Spondyloarthritis (axSPA)
Not applicableRecruitingAssistance Publique - Hôpitaux de Paris722024-08-272025-10-01
A LONGITUDINAL OBSERVATIONAL STUDY to EVALUATE the EFFICACY of MOVEMENT and IMPLEMENT CONCRETE MOVEMENT RECOMMENDATIONS with the HELP of MOBILITY TRACKING with SMARTWATCHES in SUBJECTS with AXIAL SPONDYLOARTHRITIS
Smartwatch - Axial Spondyloarthritis, Axial Spondyloarthritis (AxSpA)
RecruitingUniversity of Bonn502024-04-012025-02-18
Retrospective Case-Control Study for Developing an Artificial Intelligence (AI) Tool for Lesion Detection Using Magnetic Resonance Imaging (MRI) and Clinical Variables for Early Diagnosis of Axial Spondyloarthritis (axSpA)
Axial Spondyloarthritis (AxSpA)
CompletedÁngel Alberich Bayarri9252023-02-192025-04-16
Effect of Aerobic Exercises on Axial Spondyloarthropathy
Home Exercise, Aerobic exercise - Axial Spondyloarthritis (AxSpA), Aerobic Exercise
Not applicableCompletedYeşim Ozge Gunduz Gul542021-11-012024-11-21
A Real-world Study of Imraldi® Use
Adalimumab - Arthritis, Rheumatoid (RA), Axial Spondyloarthritis (axSpA)
CompletedBiogen10002019-06-302023-04-18
Multimodal Pulmonary Rehabilitation in Radiographic Axial Spondyloarthritis
Multimodal Pulmonary Rehabilitation - Axial Spondyloarthritis (AxSpA)
Not applicableCompletedBalikesir University202018-05-302026-02-25
Evaluation of the Expression and Functions of the KIR3DL2 Receptor and the Anti-inflammatory Activity of IPH4102 in Blood Samples
blood samples - Axial Spondyloarthritis (axSpA), Ankylosing Spondylitis (AS)
Not applicableCompletedAssistance Publique Hopitaux De Marseille242017-12-182026-05-08
A Study to Assess the Effects of Certolizumab Pegol on the Reduction of Anterior Uveitis (AU) Flares in Axial Spondyloarthritis Subjects With a Documented History of AU
Certolizumab Pegol - Axial Spondyloarthritis (axSpA), Anterior Uveitis (AU)
Phase 4CompletedUCB Biopharma SRL892016-12-212026-06-23
A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers
Breast milk sampling, Certolizumab Pegol - Axial Spondyloarthritis (AxSpA), Non-radiographic Evidence-AxSpA
Phase 1CompletedUCB BIOSCIENCES, Inc.172014-09-012018-04-03
A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the Placenta
Blood sampling from mother, Blood sampling from infant, Blood sampling from umbilical cord - Axial Spondyloarthritis (AxSpA), Non-radiographic Evidence-AxSpA
Phase 1CompletedUCB BIOSCIENCES, Inc.372014-01-012019-06-21

Narrower conditions

Axial Spondyloarthritis (16)  ·  Spondylitis, Ankylosing (6)  ·  Arthritis, Psoriatic (4)  ·  Arthritis, Rheumatoid (4)  ·  Crohn Disease (3)  ·  Autoimmune Diseases (2)  ·  Non-Radiographic Axial Spondyloarthritis (2)  ·  Breast Feeding (1)  ·  Colitis, Ulcerative (1)  ·  Disease (1)  ·  Dyspnea (1)  ·  Rheumatic Diseases (1)  ·  Spondylarthritis (1)  ·  Uveitis, Anterior (1)

Broader conditions

Ankylosis (16)  ·  Arthritis (16)  ·  Bone Diseases (16)  ·  Joint Diseases (16)  ·  Musculoskeletal Diseases (16)  ·  Spinal Diseases (16)  ·  Spondylarthropathies (16)  ·  Spondylitis (16)  ·  Spondylarthritis (15)  ·  Connective Tissue Diseases (5)  ·  Skin and Connective Tissue Diseases (5)  ·  Immune System Diseases (4)  ·  Psoriasis (4)  ·  Rheumatic Diseases (4)  ·  Skin Diseases (4)

Interventions

Certolizumab Pegol (3)  ·  Adalimumab (1)  ·  Blood Specimen Collection (1)  ·  Exercise (1)  ·  Physical Therapy Modalities (1)  ·  Sagittal Abdominal Diameter (1)  ·  mycophenolic adenine dinucleotide (1)  ·  secukinumab (1)  ·  upadacitinib (1)

Sponsors

UCB BIOSCIENCES, Inc. (2)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Assistance Publique Hopitaux De Marseille (1)  ·  Balikesir University (1)  ·  Biogen (1)  ·  Chinese PLA General Hospital (1)  ·  Grey Wolf Therapeutics (1)  ·  Istanbul University - Cerrahpasa (1)  ·  Royal United Hospitals Bath NHS Foundation Trust (1)  ·  Sint Maartenskliniek (1)  ·  The University of Texas Health Science Center, Houston (1)  ·  UCB Biopharma SRL (1)  ·  University of Bonn (1)  ·  Yeşim Ozge Gunduz Gul (1)  ·  Ángel Alberich Bayarri (1)

Countries

Netherlands (5)  ·  Germany (4)  ·  Spain (4)  ·  France (3)  ·  Turkey (Türkiye) (3)  ·  United States (3)  ·  Belgium (2)  ·  Poland (2)  ·  Switzerland (2)  ·  United Kingdom (2)  ·  Australia (1)  ·  China (1)  ·  Czechia (1)  ·  Ireland (1)  ·  Italy (1)

Top investigators

Ajda Bal, MD, Professor (1)  ·  Jian Zhu (1)  ·  Raj Sengupta, Professor (1)  ·  Savannah M Bowman, MD (1)

Results publications

PMID 28814432, PMID 29030361, PMID 33854572, PMID 36124947, PMID 37632666, PMID 41919656

NIH funding

2016 (1), 2025 (1)